Ranch Capital Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Ranch Capital Advisors’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100	Closed	-$8K	–	451
2021 Q3	$8K	Hold	100	–	–	0.01%	500
2021 Q2	$8K	Hold	100	–	–	﹤0.01%	684
2021 Q1	$7K	Sell	100 -155	-61%	-$12.1K	﹤0.01%	695
2020 Q4	$18K	Hold	255	–	–	0.01%	497
2020 Q3	$16K	Hold	255	–	–	0.01%	508
2020 Q2	$16K	Hold	255	–	–	0.01%	522
2020 Q1	$14K	Hold	255	–	–	0.01%	525
2019 Q4	$17K	Buy	+255	New	+$15.5K	0.01%	536

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Ranch Capital Advisors's PJP Position: Q4 2021 in Review

Ranch Capital Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2021, closing a stake of 100 shares — an estimated $8K sold.

Ranch Capital Advisors first reported a position in PJP in Q4 2019 and held it in 8 quarters. The position peaked at $18K in Q4 2020. 82 funds tracked by Wall St. Rank hold PJP as of Q4 2021.

Ranch Capital Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2021 after selling out during the quarter.
Ranch Capital Advisors sold 100 Invesco Pharmaceuticals ETF shares in Q4 2021, an estimated $8K.
Ranch Capital Advisors first reported a position in Invesco Pharmaceuticals ETF in Q4 2019 and held it in 8 quarters.
Ranch Capital Advisors's Invesco Pharmaceuticals ETF position peaked at $18K in Q4 2020.
82 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2021.

Based on Ranch Capital Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.